argyrotsipi/train-dataset huggingface dataset:
Points of Order — House of Commons, 2017-12-19
Topic: Health
John Simon Bercow (Conservative, Centre-right): I am very grateful to the hon. Gentleman for his point of order. The short answer is that he would certainly have an opportunity at business questions on Thursday to raise this matter with the Leader of the House if he is so inclined. There are various other means by which matters can be raised and the hon. Gentleman will be familiar with the arsenal of weapons available to a Back-Bench Member. I completely understand his concern. If he is asking me, "Is there at least one method of raising it before we rise for the Christmas recess?" the answer is yes and there may prove to be more Bills Presented Pension Benefits (Ill Health) Bill Presentation and First Reading (Standing Order No. 57) John Mann presented a Bill to require pension providers to make lump sum payments and other pension benefits available to people with ill health, including people with a terminal diagnosis, prior to such people reaching minimum pension age; and for connected purposes Bill read the First time; to be read a Second time on Friday 27 April 2018, and to be printed (Bill 143). Access to Radiotherapy Bill Presentation and First Reading (Standing Order No. 57) Tim Farron, supported by Mr Jim Cunningham, Norman Lamb, Stephen McPartland, Layla Moran, Grahame Morris and Tom Brake, presented a Bill to make provision to improve access to radiotherapy treatment in England; to define access in terms of the time that patients are required to travel to places providing treatment; to specify 45 minutes as the maximum time patients are to travel; and for connected purposes Bill read the First time; to be read a Second time on Friday 11 May 2018, and to be printed (Bill 144).
Finance (No. 2) Bill — House of Commons, 2017-12-19
Topic: Health
Abimbola Afolami (Conservative, Centre-right): I will conclude my remarks by saying that it is important when we talk about these issues—in this House or outside—always to remember that improving the performance of the health service, the economy or anything relating to Government policy will benefit everybody in this country, if we make the right judgments and the right policy.
Prevention and Suppression of Terrorism — House of Commons, 2017-12-19
Topic: Defense
Stephen Charles Kerr (Conservative, Centre-right): My hon. Friend mentions the occasions when the intelligence services have foiled the plotters and their dastardly plans. Will she comment on the importance of co-operation with the intelligence services of our friends and partners in Europe, in North America and across the world, and on the important part that passing intelligence between those agencies plays in making the picture more complete so that action can be taken to prevent loss of life in such incidents?
A Better Defence Estate — House of Commons, 2019-02-28
Topic: Defense
Ruth Smeeth (Labour, Centre-left): The Minister knows that I have grave reservations about the consolidation of the estate, not least because it could take a military family away from other communities across the country. That presents challenges in recruitment and in the general understanding of the military. How is the Minister engaging with communities and the wider military family, given that we have delayed some of these proposals yet again and are just providing more uncertainty?
Daesh — House of Commons, 2017-10-17
Topic: Defense
Alistair James Hendrie Burt (Conservative, Centre-right): It is a good question. There is a certain amount that can be said and cannot be said. We are all aware that Daesh operates in an increasingly sophisticated way. It should never be underestimated. Those who are fighting in the region fight not just physically but through the internet and through the spread of false ideological information and the like. The UK takes certain steps to deal with this, in company with partners, through cyber-protection and the like. I can assure the hon. Gentleman that as Daesh’s attempts to infiltrate the minds of people have stepped up, so have our attempts to counter that.
International Investment — House of Commons, 2017-10-17
Topic: Defense
Gregory David Clark (Conservative, Centre-right): I am grateful to the hon. Gentleman for his questions, although I am surprised that he did not want to welcome the investment decision in Bombardier. In response to his—perfectly reasonable—question, "Why now?", it is right to upgrade our systems for scrutiny periodically. A national security risk assessment was carried out recently, which correctly pointed out that smaller companies have the potential to pose a threat to national security, and these measures respond to that. We are publishing a Green Paper; Parliament is being invited to scrutinise it, as the essence of a Green Paper is that it is published for Parliament, as well as people in the outside world, to examine. On military technology and the scrutiny of arms sales, I think the hon. Gentleman should know that that is already subject to a licensing procedure.
International Investment — House of Commons, 2017-10-17
Topic: Defense
Robert Alexander Stewart (Conservative, Centre-right): Will my right hon. Friend confirm to the House that robust due diligence is always carried out on foreign investment when it might afford other Governments control of systems that are closely linked to national security, such as the grid?
International Investment — House of Commons, 2017-10-17
Topic: Defense
Gregory David Clark (Conservative, Centre-right): That is the essence of the proposals, and it is necessary to update them from time to time in line with the recommendations that arose from the national security risk assessment. It is very important—it is the first duty of Government—to make sure that we are protected from hostile threats.
International Investment — House of Commons, 2017-10-17
Topic: Defense
Alan Mak (Conservative, Centre-right): I welcome the Secretary of State’s statement and the investment in Bombardier. As the fourth industrial revolution accelerates and new technologies emerge, will he consider introducing a call-in mechanism to allow flexibility when the Government scrutinise transactions for national security concerns?
International Investment — House of Commons, 2017-10-17
Topic: Defense
Gregory David Clark (Conservative, Centre-right): My hon. Friend is a great champion of the need to prepare for the fourth industrial revolution, if we are to benefit from it. Part of the reason for this Green Paper is consistent with the high standards that we have always had in this country for ensuring that our systems are up to date. We are suggesting that, in certain sectors that are relevant to national security, it would be possible, subject to the results of the consultation, to scrutinise transactions to assess whether they posed a problem.
International Investment — House of Commons, 2017-10-17
Topic: Defense
Gregory David Clark (Conservative, Centre-right): The proposals can be introduced through secondary legislation, and I hope that they will find favour with the House so that we can proceed with that. There is an ability to act through other measures if there is a threat to national security, but the essence of these proposals is that this can be done in anticipation, rather than when a threat has crystallised. This is the right way to proceed, rather than waiting for a threat to be identified as imminent. This is about being prepared.
International Investment — House of Commons, 2017-10-17
Topic: Defense
Gregory David Clark (Conservative, Centre-right): That is exactly what is proposed in the Green Paper. The focus is on national security, which is an important responsibility for the Government. It is important that investors and businesses know the procedures so that they can have the greatest certainty when conducting business, including when contemplating takeovers.
The Rohingya and the Myanmar Government — House of Commons, 2017-10-17
Topic: Defense
Paul Stuart Scully (Conservative, Centre-right): Does my hon. Friend agree that, while it is absolutely right that we should suspend our military programme with the Burmese military, it is a matter of regret that the people left training the Burmese military at the moment are the Russians?
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
Mark Julian Francis Pawsey (Conservative, Centre-right): The right hon. Gentleman is setting out the harm caused by tobacco. As a recent convert to the benefit of e-cigarettes in assisting people to stop smoking, I wonder whether he will be talking about the valuable role they play. Does he agree that it is a bit of a shame that the tobacco control plan does not go further in recognising the role that e-cigarettes can play?
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
Mark Julian Francis Pawsey (Conservative, Centre-right): I accept that the right hon. Gentleman wishes to park the issue of whether e-cigarettes should be available on prescription, but does he think that e-cigarette manufacturers should have a little more freedom—the tobacco products directive places restrictions on the advertising of e-cigarettes—to tell people about the nature of their products and how they can help people to switch from tobacco?
Fire Safety and Cladding — House of Commons, 2019-01-23
Topic: Defense
Sarah Ann Jones (Labour, Centre-left): I am sorry to keep intervening—my hon. Friend is being incredibly generous—but I just want to make a point about waking watch. Having talked to the fire services, I know that it is not an ideal situation. The fire services are worried that companies have come out of the woodwork and started doing waking watch, but people are not always well-trained and there are not always enough of them on site. Waking watch is very much a temporary measure. To have 19 months of waking watch is expensive, but also not ideal, and we cannot be 100% sure that these people are trained and doing what they are supposed to be doing.
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
Stephen Charles Kerr (Conservative, Centre-right): I thank my hon. Friend for his intervention and his moving and impactful contribution earlier Behind the numbers on lives and costs, there is above all else the human suffering and the suffering of the families who lose family members to this terrible disease. I welcome any and all efforts to help people across the UK stop smoking.
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I thank the hon. Member for Washington and Sunderland West (Mrs Hodgson), my ministerial shadow and my friend—she certainly is that. I congratulate the right hon. Member for Rother Valley (Sir Kevin Barron) on securing this important debate. The Backbench Business Committee was an excellent innovation that arrived in this House at the same time as me—there is no correlation between those two things, I should point out—and debates such as this would not necessarily have happened without it. So well done to the right hon. Gentleman, and to all the Members who have participated. As the shadow Minister said, it is Stoptober, which is an excellent time to have this debate, but of course our passion to cut back on smoking rates is not confined to October Let me say a bit about the tobacco control plan and try to respond, as far as I can, to the points raised in the debate. My ministerial brief covers a wide area: public health, primary care, and cancer. That might appear to be a disparate agenda, but there is a plan. For me, all of my responsibilities come back to prevention and in particular how we prevent some of the major diseases; cancer is, of course, still the biggest preventable killer in our country, and the link to smoking is obvious and has been given by many Members. To give some obvious examples, our work to tackle the harmful use of alcohol, our strategy to tackle obesity and specifically childhood obesity, and our tobacco control plan are all about doing more to prevent ill health in our country, and above all cancer The TCP is not an end in itself; it is part of a plan. The shadow Minister kindly said that publishing it was down to me. At our very first health orals, she asked when it would be published, and I gave the answer that it would be published by the summer recess. She then shouted out, "Which summer recess?", but the plan had been started and I wanted to get it right and to get it out. It is amazing what announcing things at oral questions will do to our officials. Anyway, we got it out, and I am very pleased with it The last TCP ran from 2011 to 2015 and was considered highly successful; I am grateful to the many Members from all parties for saying that. All the ambitions we set out in that plan were exceeded. We introduced a significant amount of legislation over the course of the plan, as did the Labour Government before then. There was the ban itself, then the ban on smoking in cars containing children, and then, last year, the introduction of standardised packaging, which is a first for Europe. The UK remains a world leader in tobacco control, and Governments of both parties have a proven track record in reducing harm caused by tobacco. The country has made a significant reduction in the prevalence of smoking over the past 25 years, from 27% in 1993 to just over 15% today. That is some achievement.
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
William James Quince (Conservative, Centre-right): At the moment we have symbols on every bottle of alcohol sold in the UK. I appreciate that this is under EU rules, so other Government Departments would need to look at this, but could we consider having "no smoking while pregnant" symbols on all smoking products, rather than just one in six, as is the case at present?
Tobacco Control Plan — House of Commons, 2017-10-19
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I will look at that point; as ever, my hon. Friend makes a pertinent point from the Back Benches—where I do not think he will be forever, I might add. [Interruption.] It is evidently not my decision I have given the relevant figures, and we are now considered by independent experts to have the best tobacco control measures in Europe. We published the new plan this year to build on that success, but there is no room for patting ourselves on the back in this game, and we still have a huge amount to do We still have 7.3 million smokers. That exerts a huge impact on our communities and our NHS. Tobacco use is the biggest contributor to cancer, accounting for more than one in four UK cancer deaths, and nearly a fifth of all cancer cases in this country. Research by the Independent Cancer Taskforce reported that up to two thirds of long-term smokers will die as a result of smoking if they do not quit. We have heard from a number of Members across the House about people whom they have loved and lost, and they are not statistics; they are people’s mothers and fathers, and sons and daughters, who have been lost to cancer. Cancer is not contracted through smoking alone, of course, although it accounts for a huge part of the cancer rate. We must remember that 200 people die every day due to smoking; I think every Member will join me in saying I want us to do better than that The plan sets our interim ambitions en route to that goal. Over the next five years we want to reduce the prevalence of adult smokers to 12%. In answer to my hon. Friend the Member for Harrow East (Bob Blackman), I would like to go lower than that, but that is the current figure in the plan. It is not necessarily an end-point, however, and it is not an end in itself. We should also remember the prevalence of 15-year-olds who regularly smoke. We want to get that down to 3%, and the prevalence of pregnant smokers—which so many Members have mentioned today—down to 6%. We want to reduce the burning injustice—a number of Members have used that term today— that sees some of the poorest in our society die on average nine years earlier than the richest, so we will focus, as the plan says, on people in routine and manual occupations We want to focus on other groups particularly affected by smoking, such as people with mental health conditions and those in prisons. The hon. Member for Stockton South (Dr Williams) rightly spoke about that being part of a wider poverty reduction programme. That has to be central to the plan, which is not just owned by the Department of Health and me. It is a cross-governmental plan and everything that we do should be part of that aim to reduce poverty. That is why the Prime Minister said what she did. I guess that the hon. Gentleman does not agree with everything she said, but surely he must agree with her words on the steps of Downing Street about poverty reduction.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Huw William Merriman (Conservative, Centre-right): I stand here as an advocate for my constituent, Ms Carol Short, who describes her son as a 26-year-old locked in a man’s body, but unable to do much more than a 10-year-old. Does the right hon. Gentleman agree that it is shocking, with the clinical commissioning groups and all the funding that comes from the public sector, that we still cannot get this message through? Might one solution be shorter length prescriptions, to increase the likelihood that women receive more regular advice?
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): The hon. Lady makes a very good point Further warnings were issued. In 2000, a patient information leaflet from the producer, Sanofi, said: "It is known that women who have epilepsy have a slightly higher risk of having a child with an abnormality than other women. Women who have to take Epilim in the first 3 months of pregnancy to control their epilepsy have about a 1-2% chance of having a baby with Spina Bifida." In 2005, Sanofi added: "Some babies born to mothers who took Epilim during pregnancy may develop less quickly than normal and may require additional educational support" and that some "babies born to mothers who took Epilim…during pregnancy may develop less quickly than normal or have autistic disorders." Warnings were emerging over the years, but nothing was done to ensure that patients were told. Why did patients have to wait almost 30 years to be warned of the risks Janet Williams and Emma Murphy, whom the right hon. Member for North Norfolk (Norman Lamb) mentioned and whom I have had the privilege of meeting, are tenacious and brave women who have campaigned for years and set up a support group for affected families. I pay tribute to them, and I want to tell the House a little bit about their family situations. Janet has two sons aged 26 and 28: Lee and Philip. Janet took Epilim, but nothing else, during both pregnancies. She told me: "I wasn’t offered anything else—and no one told me of the risks." Lee, at 26, has curvature of the spine, Asperger’s, learning difficulties and memory problems, and he cannot hold down a job. Philip, at 28, has even more problems. He has problems with hearing, vision, speech, language and walking, as well as floppy joints. He is still fully dependent on Janet Emma had her children a generation later. She has five children, aged eight to 14: Chloe, Lauren, Luke, Erin and Kian. They have all been diagnosed with a number of symptoms. All have varied problems, including autism, incontinence, deafness, cerebral palsy and curvature of the spine, and all are slow to develop. Emma took the same dose of Epilim during each pregnancy. She told me that she questioned that, but was told that it was the best drug to control her seizures and that her baby would be fine. She took no other drugs during her pregnancies. No one warned her of the risks The tragedy is that those two women represent more than 1,000 others in their support group, the Fetal Anti Convulsant Syndrome Association. Together, they founded the Independent Fetal Anti Convulsant Trust, a registered charity, to campaign for better awareness of the risks of taking valproate, to prevent further such difficulties occurring, and to challenge the Government. There is, as I say, a case to answer, and I do not believe that we would be here today were it not for these two women.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): I certainly think that has to be looked at as part of the case that Ministers have to answer I would like to say much more but time prohibits me. We have heard some of the terrible statistics that have already been cited about the 20,000 children who could have been affected since the risks were first known about, the 400 children who are still born each year with symptoms, the 28,000 women of childbearing age—according to ONS figures—who are still being prescribed the drug, and the 68% of women in this situation who say that they are not properly informed of the risks What do I ask of Ministers? I ask the Minister to agree that significantly more needs to be done urgently to raise awareness of the risks of taking sodium valproate among pregnant women and those who could become pregnant. Does he agree that although Ministers might have come to know about the risks only relatively recently, the producer Senofi, the MHRA and its predecessor, the Committee on Safety of Medicines, knew about them and should have done more to address them? They should have published information and improved warnings years ago Does the Minister accept that the support needed by mothers such as Janet and Emma, who have to care for their children with foetal valproate syndrome, is major and may be lifelong, and that much more needs to be done to consider how that support can be improved and funded? Janet and Emma tell me that the current provision through local councils and health authorities is wholly insufficient and that care plans are needed for the many affected children Is there any reason why, as I said at the outset, Ministers cannot look at what we in this country can do to support these families now, without further delay, and certainly without awaiting the final decision of the European Commission regarding the link between sodium valproate and birth defects? After all, we are leaving the EU. Does the Minister now have full confidence in the MHRA’s ability to effectively inform and guide healthcare professionals on the use of the prescription of sodium valproate for epilepsy, and does he think the same can be said of the MHRA’s involvement over the years? Finally, will the Minister, at an early date, meet Janet Williams and Emma Murphy, as well as a group of Members who are concerned about this issue, to respond to their concerns and to my call that our Government at the very least have a case to answer?
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Miriam Jane Alice Davies (Conservative, Centre-right): I thank the right hon. Member for North Norfolk (Norman Lamb) for securing this important debate and the Backbench Business Committee for allowing us time in the main Chamber to consider this issue. I also pay tribute to campaigners who have done so much to raise it As one who works closely with constituents so gravely affected by the use of Primodos as a pregnancy test, I recognise the huge importance of airing such concerns on behalf of our constituents as widely as possible so that all can hear. There is so much work to do on Primodos, and I hope to bring those concerns to the Prime Minister shortly. As the chair of the all-party parliamentary group on women in Parliament and a former member of the Women and Equalities Committee, I want to take the time today to note, along with colleagues, that many Backbench Business and Westminster Hall debates seem to focus on women’s health issues: Valproate, Primodos, vaginal mesh. It is great to see such an issue raised in the main Chamber.